Clonality of erythromycin resistance in Francisella tularensis

J Antimicrob Chemother. 2016 Oct;71(10):2815-23. doi: 10.1093/jac/dkw235. Epub 2016 Jun 21.

Abstract

Objectives: We analysed diverse strains of Francisella tularensis subsp. holarctica to assess if its division into biovars I and II is associated with specific mutations previously linked to erythromycin resistance and to determine the distribution of this resistance trait across this subspecies.

Methods: Three-hundred and fourteen F. tularensis subsp. holarctica strains were tested for erythromycin susceptibility and whole-genome sequences for these strains were examined for SNPs in genes previously associated with erythromycin resistance. Each strain was assigned to a global phylogenetic framework using genome-wide canonical SNPs. The contribution of a specific SNP to erythromycin resistance was examined using allelic exchange. The geographical distribution of erythromycin-resistant F. tularensis strains was further investigated by literature search.

Results: There was a perfect correlation between biovar II strains (erythromycin resistance) and the phylogenetic group B.12. Only B.12 strains had an A → C SNP at position 2059 in the three copies of the rrl gene. Introducing 2059C into an rrl gene of an erythromycin-susceptible F. tularensis strain resulted in resistance. An additional 1144 erythromycin-resistant strains were identified from the scientific literature, all of them from Eurasia.

Conclusions: Erythromycin resistance in F. tularensis is caused by an A2059C rrl gene mutation, which exhibits a strictly clonal inheritance pattern found only in phylogenetic group B.12. This group is an extremely successful clone, representing the most common type of F. tularensis throughout Eurasia.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial / genetics
  • Erythromycin / pharmacology*
  • Francisella tularensis / drug effects*
  • Francisella tularensis / genetics*
  • Genes, Bacterial
  • Genome, Bacterial
  • Mutation
  • Phenotype
  • Phylogeny
  • Polymorphism, Single Nucleotide*
  • RNA, Ribosomal, 23S / genetics

Substances

  • Anti-Bacterial Agents
  • RNA, Ribosomal, 23S
  • Erythromycin